Results 331 to 340 of about 427,029 (392)

Roles of TIF1β in Leukemic Stem Cell Through SETDB1‐Dependent and Independent Mechanisms

Cancer Science, EarlyView.
In leukemic stem cell, BCR::ABL cooperates with TIF1β to open chromatin at oncogenes and close chromatin at differentiation regulators, driving leukemic reprogramming. In TIF1β‐deficient stem cell, the loss of TIF1β inverts this balance, showing closed chromatin at oncogenes and open chromatin at differentiation regulators.
Mariko Morii, Sho Kubota, Goro Sashida
wiley   +1 more source

Treatment-Free Remission in Chronic Myeloid Leukemia: Revisiting the "W" Questions. [PDF]

Eur J Haematol
Bruzzese A, Vigna E, Martino EA, Amodio N, Labanca C, Mendicino F, Lucia E, Olivito V, Morabito F, Gentile M.   +9 more
europepmc   +1 more source

Innate CD8 T-cells as a potential predictive biomarker for deep molecular response in chronic myeloid leukemia patients. [PDF]

Cancer Immunol Immunother
Cayssials E, Lefèvre L, Decroos A, Jacomet F, Piccirilli N, Tartarin F, Guilhot F, Chomel JC, Rousselot P, Nicolini FE, Ragot S, Gombert JM, Roy L, Herbelin A, Barbarin A.   +14 more
europepmc   +1 more source

Interstitial Pneumonia Triggered by H1N1 Influenza A Virus as the Initial Presentation of Chronic Myeloid Leukemia. [PDF]

Mediterr J Hematol Infect Dis
Su Z, Wang F.
europepmc   +1 more source

Improvement in survival of patients with higher risk but not lower risk myelodysplastic syndromes over 20 years: A retrospective study from Nagasaki, Japan

British Journal of Haematology, EarlyView.
Takafumi Furumoto, Koji Ando, Eo Toriyama, Tomoko Hata, Hikaru Sakamoto, Masahiko Chiwata, Hideaki Kitanosono, Jun Nakashima, Takeharu Kato, Masataka Taguchi, Makiko Horai, Hidehiro Itonaga, Shinya Sato, Yasushi Sawayama, Daisuke Imanishi, Yoshitaka Imaizumi, Tatsuro Jo, Shinichiro Yoshida, Yukiyoshi Moriuchi, Yasushi Miyazaki   +19 more
wiley   +1 more source

Early <i>BCR::ABL1</i> Reduction as a Predictor of Deep Molecular Response in Pediatric Chronic-Phase Chronic Myeloid Leukemia. [PDF]

Cancers (Basel)
Wang X, An W, Liu C, Zhang B, Chen Y, Wan Y, Li X, Liu L, Liu F, Zhang L, Zou Y, Chen X, Chen Y, Guo Y, Hu T, Zhang Y, Zhu X, Yang W.   +17 more
europepmc   +1 more source

Immune‐related toxicity profile after haematopoietic stem cell transplantation in patients with B‐ALL given combination immunotherapy with rituximab, inotuzumab and blinatumomab

British Journal of Haematology, EarlyView.
Olayinka Okeleji, David McCall, Branko Cuglievan, Amber Gibson, Demetrios Petropoulos, Priti Tewari, Jeremy Connors, Irtiza N. Sheikh   +7 more
wiley   +1 more source

Use of Patient-Reported Outcome Measures in Clinical Studies of Chronic Myeloid Leukemia: A Scoping Literature Review. [PDF]

Curr Hematol Malig Rep
Flynn KE, Saini L, Kataria A, Jadhav K, Yang D, Wei D.   +5 more
europepmc   +1 more source

2025 European LeukemiaNet recommendations for the management of chronic myeloid leukemia. [PDF]

Leukemia
Apperley JF, Milojkovic D, Cross NCP, Hjorth-Hansen H, Hochhaus A, Kantarjian H, Lipton JH, Malhotra H, Niederwieser D, Radich J, Rousselot P, Saussele S, Schiffer CA, Silver R, Soverini S, Stenke L, Turkina A, Casado LF, Castagnetti F, Cervantes F, Clark RE, Cortes J, Deininger M, Hughes TP, Janssen J, Jiang Q, Kim DW, Larson RA, Mahon FX, Mauro M, Mayer J, Nicolini FE, Pane F, Rea D, Richter J, Rosti G, Saglio G, Hehlmann R.   +37 more
europepmc   +1 more source